These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28646205)

  • 41. Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.
    Wu X; Li Z; Li X; Tian Y; Fan Y; Yu C; Zhou B; Liu Y; Xiang R; Yang L
    Drug Des Devel Ther; 2017; 11():939-946. PubMed ID: 28356719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection and Molecular Characterization of Escherichia coli Strains Producers of Extended-Spectrum and CMY-2 Type Beta-Lactamases, Isolated from Turtles in Mexico.
    Cortés-Cortés G; Lozano-Zarain P; Torres C; Castañeda M; Sánchez GM; Alonso CA; López-Pliego L; Mayen MG; Martínez-Laguna Y; Rocha-Gracia Rdel C
    Vector Borne Zoonotic Dis; 2016 Sep; 16(9):595-603. PubMed ID: 27482752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial peptide interactions with silica bead supported bilayers and E. coli: buforin II, magainin II, and arenicin.
    Davis RW; Arango DC; Jones HD; Van Benthem MH; Haaland DM; Brozik SM; Sinclair MB
    J Pept Sci; 2009 Aug; 15(8):511-22. PubMed ID: 19591202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.
    Johnson JR; Kuskowski MA; Gajewski A; Sahm DF; Karlowsky JA
    J Infect Dis; 2004 Nov; 190(10):1739-44. PubMed ID: 15499527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli.
    Keeney D; Ruzin A; McAleese F; Murphy E; Bradford PA
    J Antimicrob Chemother; 2008 Jan; 61(1):46-53. PubMed ID: 17967850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial drug resistance genes do not convey a secondary fitness advantage to calf-adapted Escherichia coli.
    Khachatryan AR; Hancock DD; Besser TE; Call DR
    Appl Environ Microbiol; 2006 Jan; 72(1):443-8. PubMed ID: 16391076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
    Chen X; Liu Y; Lin A; Huang N; Long L; Gang Y; Liu J
    Biomater Sci; 2018 Jun; 6(7):1923-1935. PubMed ID: 29850668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomic Analysis of Duodenal Tissue from Escherichia coli F18-Resistant and -Susceptible Weaned Piglets.
    Wu Z; Xia R; Yin X; Huo Y; Zhu G; Wu S; Bao W
    PLoS One; 2015; 10(6):e0127164. PubMed ID: 26053838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. pMEX01, a 70kb plasmid isolated from Escherichia coli that confers resistance to multiple β-lactam antibiotics.
    Hernandez-Flores JL; Pérez JC; Gutiérrez CS; Hernández AC; Alonso GS; Hernández SP; Gómez SR; Fernández F; Loske AM; Guillén JC
    Braz J Microbiol; 2018; 49(3):569-574. PubMed ID: 29449172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fitness and molecular mechanisms of resistance to rifaximin in in vitro selected Escherichia coli mutants.
    Pons MJ; Mensa L; Gascón J; Ruiz J
    Microb Drug Resist; 2012 Aug; 18(4):376-9. PubMed ID: 21711150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigations of the synergistic enhancement of antimicrobial activity in mixtures of magainin 2 and PGLa.
    Glattard E; Salnikov ES; Aisenbrey C; Bechinger B
    Biophys Chem; 2016 Mar; 210():35-44. PubMed ID: 26099623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea.
    Shin JH; Jung HJ; Lee JY; Kim HR; Lee JN; Chang CL
    Microb Drug Resist; 2008 Sep; 14(3):221-6. PubMed ID: 18707554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ESBL-producing Escherichia coli isolated from children with acute diarrhea - antimicrobial susceptibility, adherence patterns and phylogenetic background.
    Franiczek R; Sobieszczańska B; Turniak M; Kasprzykowska U; Krzyzanowska B; Jermakow K; Mokracka-Latajka G
    Adv Clin Exp Med; 2012; 21(2):187-92. PubMed ID: 23214282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic elements associated with antimicrobial resistance among avian pathogenic Escherichia coli.
    Awad A; Arafat N; Elhadidy M
    Ann Clin Microbiol Antimicrob; 2016 Nov; 15(1):59. PubMed ID: 27887603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluoroquinolone resistance in clinical and environmental isolates of Escherichia coli in Mexico City.
    Amábile-Cuevas CF; Arredondo-García JL; Cruz A; Rosas I
    J Appl Microbiol; 2010 Jan; 108(1):158-62. PubMed ID: 19548885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes.
    Westerhoff HV; Zasloff M; Rosner JL; Hendler RW; De Waal A; Vaz Gomes A; Jongsma PM; Riethorst A; Juretić D
    Eur J Biochem; 1995 Mar; 228(2):257-64. PubMed ID: 7705337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic resistance, virulence factors and biofilm formation ability in Escherichia coli strains isolated from chicken meat and wildlife in the Czech Republic.
    Pavlickova S; Klancnik A; Dolezalova M; Mozina SS; Holko I
    J Environ Sci Health B; 2017 Aug; 52(8):570-576. PubMed ID: 28494209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
    Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H
    J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quinolone co-resistance in ESBL- or AmpC-producing Escherichia coli from an Indian urban aquatic environment and their public health implications.
    Bajaj P; Kanaujia PK; Singh NS; Sharma S; Kumar S; Virdi JS
    Environ Sci Pollut Res Int; 2016 Jan; 23(2):1954-9. PubMed ID: 26498967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.